Overview Biotech Insight publishes a monthly stock newsletter and weekly news alerts. The newsletter usually highlights a particular company while the alerts talk more about topical opportunities and news events. The editorial staff always seeks to place newsworthy events in a context that has value to the investor. Information is distributed by email and also archived on the web.
Subscribers have access to all past letters and alerts.
The purpose of Biotech Insight is to evaluate a company s science in order to demystify the concepts and to estimate the potential impact in the medical marketplace. It is important to determine whether the science is a fundamental advance or merely represents an incremental achievement. Biotech Insight offers analysis of competing approaches as well as the potential longevity of a particular technology. The primary focus of Biotech Insight is on small and mid cap companies that are in late phase two and phase three studies. The importance of being near the end of the clinical trial cycle is evident in the current investment climate.